Glioblastomas with oligodendroglial component have the same clinical phenotype as classical glioblastomas

References

• Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO Classification of Tumours of the Central Nervous System. Lyon: IARC, 2007.
   Google Scholar
• Guilfoyle MR, Weerakkody RA, Oswal A, et al. Implementation of neuro-oncology service reconfiguration in accordance with NICE guidance provides enhanced clinical care for patients with glioblastoma multiforme. Br J Cancer 2011;104:1810–5.
   PubMed Web of Science ®Google Scholar
• Bigner DD. Biology of gliomas: potential clinical implications of glioma cellular heterogeneity. Neurosurgery 1981;9:320–6.
   PubMedGoogle Scholar
• Klink B, Schlingelhof B, Klink M, Stout-Weider K, Patt S, Schrock E. Glioblastomas with oligodendroglial component-common origin of the different histological parts and genetic subclassification. Cell Oncol 2011;34:261–75.
   Google Scholar
• Burnet NG, Lynch AG, Jefferies SJ, et al. High grade glioma: Imaging combined with pathological grade defines management and predicts prognosis. Radiother Oncol 2007;85:371–8.
   PubMed Web of Science ®Google Scholar
• Salvati M, Formichella A, D‚ÄôElia A, et al. Cerebral glioblastoma with oligodendrogliomal component: analysis of 36 cases. J Neuro-Oncol 2009;94:129–34.
   PubMedGoogle Scholar
• Hilton DA, Penney M, Pobereskin L, Sanders H, Love S. Histological indicators of prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved survival. Histopathology 2004;44:555–60.
   PubMedGoogle Scholar
• Wang Y, Li S, Chen L, et al. Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcome. Neuro Oncol 2012;14:518–25.
   PubMedGoogle Scholar
• Pinto L, Mahler Araujo M, Vettore A, et al. Glioblastomas: correlation between oligodendroglial components, genetic abnormalities, and prognosis. Virchows Archiv 2008;452:481–90.
   PubMedGoogle Scholar
• Nakamura H, Makino K, Kuratsu J. Molecular and clinical analysis of glioblastoma with an oligodendroglial component (GBMO). Brain Tumor Pathol 2011; 28: 185–90.
   PubMedGoogle Scholar
• Hegi ME, Janzer RC, Lambiv WL, et al. Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial. Acta neuropathol. 2012;123:841–52.
   PubMed Web of Science ®Google Scholar
• He J, Mokhtari K, Sanson M, et al. Glioblastomas with an oligodendroglial component: a pathological and molecular study. J Neuropathol Exp Neurol 2001;60:863–71.
   PubMed Web of Science ®Google Scholar
• Homma T, Fukushima T, Vaccarella S, et al. Correlation among pathology, genotype, and patient outcomes in glioblastoma. J Neuropathol Exp Neurol 2006; 65: 846–54.
   PubMed Web of Science ®Google Scholar
• Vordermark D, Ruprecht K, Rieckmann P, et al. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26). BMC Cancer 2006;6:247.
   PubMedGoogle Scholar
• van den Bent MJ, Carpentier AF, Brandes AA, et al. Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. J ClinOncol 2006;24:2715–22.
   PubMed Web of Science ®Google Scholar
• Bruner JM, Inouye L, Fuller GN, Langford LA. Diagnostic discrepancies and their clinical impact in a neuropathology referral practice. Cancer 1997;79:796–803.
   PubMed Web of Science ®Google Scholar
• Murphy M, Loosemore A, Ferrer I, Wesseling P, Wilkins PR, Bell BA. Neuropathological diagnostic accuracy. Br J Neurosurg 2002;16:461–4.
   PubMed Web of Science ®Google Scholar
• Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 1997;79:1381–93.
   PubMed Web of Science ®Google Scholar